Archive for Medication updates
New Dispensing Fee scale April 2022
The new Dispensing Fee Scale from 1 April 2022 has an average 27 pence increase per item compared to the October 21 to March 22 Fee Scale. This however is...
March 2022 Final Price Concessions Update
Source: NHSBSA / DHSC Drug Tariff News – March Part VIIIA reimbursement prices (issued 31 March) The Department of Health and Social Care has agreed the March Drug Tariff Part VIIIA reimbursement prices...
National Patient Safety Alert: Philips Health Systems V60, V60 Plus and V680 ventilators: potential unexpected shutdown leading to complete loss of ventilation (NatPSA/2022/002/MHRA)
Source: MHRA / Gov.uk 29.3.22 Philips Health Systems informed have identified an important safety issue due to potential unexpected shutdowns of all of their V60 and V60 Plus non-invasive ventilators....
Class 2 Medicines Recall: Pfizer Limited, Accuretic 10/12.5 mg film-coated tablets, EL (22)A/16
Source: MHRA / Gov.uk 23.3.22 Pfizer Ltd are recalling batch number DD4842 as a precautionary measure due to the identification of a nitrosamine above the acceptable limit. Company name Pfizer...
Updated Hayfever Formulary
By Dr Philip Koopowitz- Dispex In preparation for the runny nose, sneezes and irritated eyes, I have looked at the current common treatments available. Whilst patients are encouraged to self-medicate,...
Class 4 Medicines Defect Information: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder and solvent for suspension for injection, EL (22)A/15
Source: MHRA / Gov.uk 17.3.22 Brancaster Pharma Limited have notified us of an issue relating to the label of the Water for Injections (solvent) packaged in each finished product pack....
Company led medicines recall: Advanced Accelerator Applications NETSPOT (Kit for the preparation of gallium Ga 68 dotatate injection) [unlicensed medicine], CLMR (22)A/02
Source: MHRA / Gov.uk 16.3.22 Advanced Accelerator Applications is recalling specific batches of this product as a precautionary measure due to an out of specification result that was identified during...
Class 4 Medicines Defect Information, Ayrton Saunders Limited, Beclometasone dipropionate 50 micrograms/dose Nasal Spray (Various Liveries), EL (22)A/14
Source: MHRA/ Gov.uk 15.3.22 Ayrton Saunders Limited have identified an error relating to the Braille printed on the cartons. MDR Number MDR 087-03/22 Company name Ayrton Saunders Limited Product description...
Class 4 Medicines Defect Information: CNX Therapeutics Ltd, Latuda film-coated tablets, EL (22)A/13
Source: MHRA / Gov.uk 14.3.22 CNX Therapeutics Ltd. have notified the MHRA that the batches of Latuda film-coated tablets listed in this notification will be released without EAN barcodes on...
NHS treats first sickle cell disease patients with life-changing drug
Source: NHS England NHS treats first sickle cell disease patients with life-changing drug Source: NHS England One of the first patients to access a ground-breaking treatment for sickle cell disease...
Class 4 Medicines Defect Information: Boots Company Plc, Decongestant Tablets and Decongestant with Pain Relief Tablets, EL (22)A/12
Source: MHRA / Gov.uk 10.3.22 Boots have identified an error with the printed patient information leaflet provided with batches of the Decongestant Tablets and Decongestant with Pain Relief Tablets. MDR...
Hayfever Formulary -2022
By Dr Philip Koopowitz- Dispex As I write this, it is difficult to imagine that the Hayfever season will soon be upon us. In preparation for the runny nose, sneezes...
